Speaker:
Uyen Hoang


Learning Objectives:

• Describe the place in therapy for injectable agents, including extended-release buprenorphine, for the management of opioid use disorder (OUD)
• Summarize prescribing restrictions and drug monitoring program requirements for the use of high-risk injectable agents for OUD
• Develop pharmacotherapy strategies for the management of OUD using injectible medications through application to a patient case

Disclosure:
Uyen has no relevant financial relationships to disclose.